| 1. | Medulloblastoma is the most common cause of brain cancer in children.
|
| 2. | Mutations in " PTCH1 " are also associated with medulloblastoma.
|
| 3. | Remarkably, the treatment with CXCL3 reduces the area of medulloblastoma lesions.
|
| 4. | Thus, CXCL3 is a potential target for medulloblastoma therapy.
|
| 5. | Depletion of BRD3 slows growth in cancer models including prostate cancer and medulloblastoma.
|
| 6. | Mice with mutations in mouse " PTCH1 " similarly develop medulloblastoma.
|
| 7. | Characterization of the role of JPO proteins that are overexpressed in metastatic medulloblastoma.
|
| 8. | Two prominent examples are pediatric neoplasms ( such as medulloblastoma ) and prostate cancer.
|
| 9. | The most common cause of damage to the flocculonodular lobe is medulloblastoma in childhood.
|
| 10. | Correct diagnosis of medulloblastoma may require ruling out atypical teratoid rhabdoid tumor ( ATRT)
|
